Revenue
No reported data
Pharmagreen Biotech Inc. (PHBI)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
Free cash flow
2018
2019
Total cash / debt
CashTotal debt
2019
2020
2021
2022
Financial statements
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Research & development | — | — | — | $3,956 | $7,619 |
| Operating expenses | $1.1M | $744,064 | $485,756 | $642,178 | $748,717 |
| Operating income | −$1.1M | −$744,064 | −$485,756 | −$642,178 | −$748,717 |
| Net income | −$875,505 | −$4.5M | −$2.5M | −$767,537 | −$1.1M |
| Basic EPSper diluted share | — | -$0.02 | -$0.03 | -$0.01 | -$0.04 |
| Diluted EPSper diluted share | — | -$0.02 | -$0.03 | -$0.01 | -$0.04 |